Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Steven Bair

Concepts (120)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hodgkin Disease
8
2023
134
2.780
Why?
Immunotherapy, Adoptive
5
2024
295
1.450
Why?
Antineoplastic Agents, Immunological
3
2025
175
1.240
Why?
Immunoconjugates
4
2025
101
1.020
Why?
Hematopoietic Stem Cell Transplantation
3
2020
572
0.940
Why?
Radiopharmaceuticals
1
2019
166
0.600
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2019
63
0.600
Why?
Fluorodeoxyglucose F18
1
2019
127
0.600
Why?
Hematologic Neoplasms
1
2020
139
0.580
Why?
Lymphoma, Large B-Cell, Diffuse
3
2025
111
0.570
Why?
Positron-Emission Tomography
1
2019
283
0.570
Why?
Programmed Cell Death 1 Receptor
1
2018
228
0.530
Why?
Drug-Related Side Effects and Adverse Reactions
1
2018
253
0.510
Why?
Antineoplastic Agents
2
2019
2051
0.480
Why?
Neoplasm Recurrence, Local
2
2020
958
0.420
Why?
Angiogenesis Inhibitors
1
2013
215
0.360
Why?
Neovascularization, Pathologic
1
2013
290
0.360
Why?
Survival Rate
3
2020
1869
0.240
Why?
Lymphoma, T-Cell, Peripheral
1
2024
16
0.220
Why?
Retrospective Studies
10
2025
14454
0.210
Why?
Peripheral Nervous System Diseases
1
2023
123
0.200
Why?
Cardiovascular Diseases
1
2013
1999
0.170
Why?
Humans
19
2025
128418
0.170
Why?
Treatment Outcome
5
2025
10152
0.170
Why?
Antibodies, Monoclonal, Humanized
1
2025
755
0.160
Why?
Lymphoma, Non-Hodgkin
1
2020
76
0.160
Why?
Disease-Free Survival
2
2020
647
0.160
Why?
Standard of Care
1
2020
71
0.160
Why?
Transplantation Conditioning
1
2020
164
0.160
Why?
Transplantation, Autologous
1
2020
214
0.160
Why?
Transplantation, Homologous
1
2020
396
0.150
Why?
Costimulatory and Inhibitory T-Cell Receptors
1
2018
7
0.150
Why?
Remission Induction
1
2019
268
0.150
Why?
Drug Resistance, Neoplasm
2
2025
749
0.150
Why?
Autografts
1
2017
42
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2023
1559
0.140
Why?
Immune Tolerance
1
2019
349
0.130
Why?
Precision Medicine
1
2020
384
0.130
Why?
Immunotherapy
1
2020
587
0.120
Why?
Adrenal Cortex Hormones
1
2018
518
0.120
Why?
Aged
5
2025
21953
0.120
Why?
NF-kappa B p50 Subunit
1
2014
21
0.120
Why?
Prognosis
2
2023
3772
0.120
Why?
Aged, 80 and over
3
2025
7033
0.110
Why?
Transcription Factor RelA
1
2014
79
0.110
Why?
Recurrence
1
2017
996
0.110
Why?
Tumor Microenvironment
1
2018
623
0.110
Why?
Chromosomes, Human, Pair 5
1
2013
29
0.110
Why?
Clinical Trials as Topic
1
2018
993
0.100
Why?
Cardiotoxins
1
2013
4
0.100
Why?
Gene Dosage
1
2013
142
0.100
Why?
Middle Aged
5
2025
30889
0.100
Why?
Medication Therapy Management
1
2013
74
0.100
Why?
Adult
5
2025
35300
0.090
Why?
Carcinoma, Renal Cell
1
2013
179
0.090
Why?
Adaptor Proteins, Signal Transducing
1
2013
391
0.090
Why?
Adolescent
3
2020
20179
0.090
Why?
Atherosclerosis
1
2014
403
0.090
Why?
Vascular Endothelial Growth Factor A
1
2013
500
0.080
Why?
Nuclear Proteins
1
2014
657
0.080
Why?
Follow-Up Studies
1
2018
4892
0.080
Why?
Kidney Neoplasms
1
2013
349
0.080
Why?
Male
5
2025
62858
0.070
Why?
Patient Care Team
1
2013
605
0.070
Why?
Female
5
2025
68154
0.070
Why?
Transcription Factors
1
2014
1628
0.070
Why?
Benzodiazepines
1
2025
129
0.060
Why?
Positron Emission Tomography Computed Tomography
1
2024
84
0.050
Why?
Antigens, CD19
1
2024
115
0.050
Why?
Inflammation
1
2014
2654
0.050
Why?
Neoplasm, Residual
1
2024
119
0.050
Why?
Lymphoma, B-Cell
1
2024
105
0.050
Why?
Signal Transduction
2
2014
4826
0.050
Why?
Young Adult
1
2018
12312
0.050
Why?
Bleomycin
1
2023
240
0.050
Why?
Ki-1 Antigen
1
2021
4
0.050
Why?
Vincristine
1
2021
109
0.040
Why?
Cyclophosphamide
1
2021
227
0.040
Why?
Rituximab
1
2021
162
0.040
Why?
Prednisone
1
2021
230
0.040
Why?
Allografts
1
2020
137
0.040
Why?
Doxorubicin
1
2021
322
0.040
Why?
Canada
1
2020
344
0.040
Why?
Pilot Projects
1
2024
1564
0.040
Why?
Comorbidity
1
2023
1543
0.040
Why?
Incidence
1
2023
2616
0.030
Why?
Vascular Cell Adhesion Molecule-1
1
2014
37
0.030
Why?
SOXF Transcription Factors
1
2014
16
0.030
Why?
E-Selectin
1
2014
53
0.030
Why?
Transcription Initiation, Genetic
1
2014
15
0.030
Why?
Regulatory Sequences, Nucleic Acid
1
2014
87
0.030
Why?
Azepines
1
2014
88
0.030
Why?
Sequestosome-1 Protein
1
2013
13
0.030
Why?
Acetylation
1
2014
237
0.030
Why?
Enhancer Elements, Genetic
1
2014
176
0.030
Why?
NF-E2-Related Factor 2
1
2013
67
0.030
Why?
Triazoles
1
2014
147
0.030
Why?
Cell Adhesion
1
2014
445
0.030
Why?
RNA Polymerase II
1
2014
317
0.020
Why?
Chromatin
1
2014
477
0.020
Why?
Base Sequence
1
2013
2135
0.020
Why?
Cell Movement
1
2014
936
0.020
Why?
Cohort Studies
1
2020
5388
0.020
Why?
Tumor Necrosis Factor-alpha
1
2014
1185
0.020
Why?
Histones
1
2014
586
0.020
Why?
Endothelial Cells
1
2014
698
0.020
Why?
Molecular Sequence Data
1
2013
2819
0.020
Why?
Quality of Life
1
2020
2680
0.020
Why?
Prospective Studies
1
2020
7036
0.020
Why?
Protein Binding
1
2014
2103
0.020
Why?
Endothelium, Vascular
1
2014
847
0.020
Why?
Transcription, Genetic
1
2014
1404
0.020
Why?
United States
1
2025
13830
0.020
Why?
Mice, Knockout
1
2014
2755
0.020
Why?
Mice
2
2014
16602
0.020
Why?
Cells, Cultured
1
2014
4001
0.020
Why?
Macrophages
1
2014
1460
0.020
Why?
Cell Line, Tumor
1
2013
3184
0.020
Why?
Mice, Inbred C57BL
1
2014
5272
0.010
Why?
Animals
2
2014
34479
0.010
Why?
Bair's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)